WKN: | 870980 |
ISIN: | US7599161095 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Repligen Corporation-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 04. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2007 | 2,05 | 4,12 | 100,98% |
2 | 2013 | 4,62 | 9,16 | 98,27% |
3 | 2020 | 81,50 | 153,20 | 87,98% |
4 | 2019 | 43,51 | 81,50 | 87,31% |
5 | 2014 | 9,16 | 16,40 | 79,04% |
6 | 2012 | 2,66 | 4,62 | 73,68% |
7 | 2005 | 1,98 | 3,38 | 70,71% |
8 | 2015 | 16,40 | 27,31 | 66,52% |
9 | 2021 | 153,20 | 229,70 | 49,93% |
10 | 2018 | 29,73 | 43,51 | 46,35% |
11 | 2010 | 2,63 | 3,38 | 28,52% |
12 | 2000 | 3,40 | 4,00 | 17,65% |
13 | 2003 | 2,60 | 3,00 | 15,38% |
14 | 2016 | 27,31 | 29,64 | 8,53% |
15 | 2023 | 158,64 | 166,20 | 4,77% |
16 | 2009 | 2,56 | 2,63 | 2,73% |
17 | 2017 | 29,64 | 29,73 | 0,30% |
18 | 2002 | 2,80 | 2,60 | -7,14% |
19 | 2024 | 166,20 | 137,70 | -17,15% |
20 | 2011 | 3,38 | 2,66 | -21,30% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2006 | 3,38 | 2,05 | -39,35% |
2 | 2008 | 4,12 | 2,56 | -37,86% |
3 | 2004 | 3,00 | 1,98 | -34,00% |
4 | 2022 | 229,70 | 158,64 | -30,94% |
5 | 2001 | 4,00 | 2,80 | -30,00% |
6 | 2025 | 137,70 | 101,65 | -26,18% |
7 | 2011 | 3,38 | 2,66 | -21,30% |
8 | 2024 | 166,20 | 137,70 | -17,15% |
9 | 2002 | 2,80 | 2,60 | -7,14% |
10 | 2017 | 29,64 | 29,73 | 0,30% |
11 | 2009 | 2,56 | 2,63 | 2,73% |
12 | 2023 | 158,64 | 166,20 | 4,77% |
13 | 2016 | 27,31 | 29,64 | 8,53% |
14 | 2003 | 2,60 | 3,00 | 15,38% |
15 | 2000 | 3,40 | 4,00 | 17,65% |
16 | 2010 | 2,63 | 3,38 | 28,52% |
17 | 2018 | 29,73 | 43,51 | 46,35% |
18 | 2021 | 153,20 | 229,70 | 49,93% |
19 | 2015 | 16,40 | 27,31 | 66,52% |
20 | 2005 | 1,98 | 3,38 | 70,71% |